ndianapolis-based Eli Lilly announced that its Lispro Injection is available at pharmacies with the significantly lower list price. Lilly said the generic of Humalog is available in both a vial and KwikPen form. Because they are the same insulin, pharmacists will be able to substitute Insulin Lispro Injection for Humalog, Eli Lilly said. The diabetes patients who are most likely to benefit from Insulin Lispro Injection are Medicare Part D beneficiaries, people with high-deductible health plans and the uninsured who use Humalog.
In January, a cost analysis for insulin was released by the nonprofit Health Care Cost Institute that showed the price of insulin doubled between 2012 and 2016. According to the report, an individual with Type 1 diabetes paid on average $2,864 for insulin in 2012 but that jumped to $5.705 by 2016. Last year the American Diabetes Association published recommendations to address the issue of affordable insulin. The ADA’s call-to-action was based on data that showed the average price of insulin nearly tripled between 2002 and 2013. In 2017, the ADA said that diabetes, including both Type 1 and Type 2, was the most expensive chronic illness in the U.S. The disease has a total cost of more than $327 billion per year, including $15 billion for insulin, the ADA said in its report.
Mike Mason, senior vice president of Connected Care and Insulins at Eli Lilly, said the availability of this generic version means more people will be able to afford their insulin. For many diabetics, the rising costs of insulin have been a serious concern. Patients have skipped doses or were rationing the doses of the life-saving drug to their inability to afford additional supplies. Mason said the company, which is one of the primary insulin providers in the U.S., will work with various health plans and the government to “work toward permanent solutions that will help every person with diabetes afford their medicines.”
Last year, Eli Lilly also opened its Lilly Diabetes Solution Center to assist people who need help paying for their Lilly insulin. The company said it has provided assistance to more than 10,000 people per month since the company established the center in August 2018.